Medical Care

Global Protein Degradation Therapy Market Insights, Forecast to 2030

Targeted protein degradation (TPD) has surfaced as a novel and innovative chemical tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates complete removal of the protein molecules from within or outside the cell. While the pioneering Proteolysis-Targeting Chimera (PROTAC) technology and molecular glues hijack the ubiquitin-proteasome system, newer modalities co-opt autophagy or the endo-lysosomal pathway.
Market Analysis and Insights: Global Protein Degradation Therapy Market
The global Protein Degradation Therapy market is projected to grow from US$ 1266 million in 2024 to US$ 1821.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
The Protein Degradation Therapy market has gained momentum as a promising approach in drug development. This innovative strategy aims to target disease-causing proteins by facilitating their degradation within cells. Proteins that contribute to diseases like cancer and neurodegenerative disorders can be selectively broken down using small molecules known as proteolysis-targeting chimeras (PROTACs) or other protein degraders. This approach offers advantages over traditional inhibition methods, potentially leading to more effective treatments with reduced side effects. As researchers delve into protein-protein interactions and cellular mechanisms, the Protein Degradation Therapy market is expanding, presenting opportunities to address previously challenging diseases and advance precision medicine. Clinical progress and continued research in this field are expected to shape the future of therapeutic interventions.
Report Covers:
This report presents an overview of global market for Protein Degradation Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Protein Degradation Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Protein Degradation Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Protein Degradation Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Protein Degradation Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Protein Degradation Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Arvinas
Nurix Therapeutics
Kymera Therapeutics
C4 Therapeutics
Segment by Type
ARV-110
ARV-471
Other
Segment by Application
Cancer
Neuroscience
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Protein Degradation Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Protein Degradation Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Protein Degradation Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Protein Degradation Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 ARV-110
1.2.3 ARV-471
1.2.4 Other
1.3 Market by Application
1.3.1 Global Protein Degradation Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Neuroscience
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Protein Degradation Therapy Market Perspective (2019-2030)
2.2 Global Protein Degradation Therapy Growth Trends by Region
2.2.1 Protein Degradation Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Protein Degradation Therapy Historic Market Size by Region (2019-2024)
2.2.3 Protein Degradation Therapy Forecasted Market Size by Region (2025-2030)
2.3 Protein Degradation Therapy Market Dynamics
2.3.1 Protein Degradation Therapy Industry Trends
2.3.2 Protein Degradation Therapy Market Drivers
2.3.3 Protein Degradation Therapy Market Challenges
2.3.4 Protein Degradation Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Protein Degradation Therapy by Players
3.1.1 Global Protein Degradation Therapy Revenue by Players (2019-2024)
3.1.2 Global Protein Degradation Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Protein Degradation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Protein Degradation Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Protein Degradation Therapy Market Concentration Ratio
3.4.1 Global Protein Degradation Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Protein Degradation Therapy Revenue in 2023
3.5 Global Key Players of Protein Degradation Therapy Head office and Area Served
3.6 Global Key Players of Protein Degradation Therapy, Product and Application
3.7 Global Key Players of Protein Degradation Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Protein Degradation Therapy Breakdown Data by Type
4.1 Global Protein Degradation Therapy Historic Market Size by Type (2019-2024)
4.2 Global Protein Degradation Therapy Forecasted Market Size by Type (2025-2030)
5 Protein Degradation Therapy Breakdown Data by Application
5.1 Global Protein Degradation Therapy Historic Market Size by Application (2019-2024)
5.2 Global Protein Degradation Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Protein Degradation Therapy Market Size (2019-2030)
6.2 North America Protein Degradation Therapy Market Size by Type
6.2.1 North America Protein Degradation Therapy Market Size by Type (2019-2024)
6.2.2 North America Protein Degradation Therapy Market Size by Type (2025-2030)
6.2.3 North America Protein Degradation Therapy Market Share by Type (2019-2030)
6.3 North America Protein Degradation Therapy Market Size by Application
6.3.1 North America Protein Degradation Therapy Market Size by Application (2019-2024)
6.3.2 North America Protein Degradation Therapy Market Size by Application (2025-2030)
6.3.3 North America Protein Degradation Therapy Market Share by Application (2019-2030)
6.4 North America Protein Degradation Therapy Market Size by Country
6.4.1 North America Protein Degradation Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Protein Degradation Therapy Market Size by Country (2019-2024)
6.4.3 North America Protein Degradation Therapy Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Protein Degradation Therapy Market Size (2019-2030)
7.2 Europe Protein Degradation Therapy Market Size by Type
7.2.1 Europe Protein Degradation Therapy Market Size by Type (2019-2024)
7.2.2 Europe Protein Degradation Therapy Market Size by Type (2025-2030)
7.2.3 Europe Protein Degradation Therapy Market Share by Type (2019-2030)
7.3 Europe Protein Degradation Therapy Market Size by Application
7.3.1 Europe Protein Degradation Therapy Market Size by Application (2019-2024)
7.3.2 Europe Protein Degradation Therapy Market Size by Application (2025-2030)
7.3.3 Europe Protein Degradation Therapy Market Share by Application (2019-2030)
7.4 Europe Protein Degradation Therapy Market Size by Country
7.4.1 Europe Protein Degradation Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Protein Degradation Therapy Market Size by Country (2019-2024)
7.4.3 Europe Protein Degradation Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Protein Degradation Therapy Market Size (2019-2030)
8.2 China Protein Degradation Therapy Market Size by Type
8.2.1 China Protein Degradation Therapy Market Size by Type (2019-2024)
8.2.2 China Protein Degradation Therapy Market Size by Type (2025-2030)
8.2.3 China Protein Degradation Therapy Market Share by Type (2019-2030)
8.3 China Protein Degradation Therapy Market Size by Application
8.3.1 China Protein Degradation Therapy Market Size by Application (2019-2024)
8.3.2 China Protein Degradation Therapy Market Size by Application (2025-2030)
8.3.3 China Protein Degradation Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Protein Degradation Therapy Market Size (2019-2030)
9.2 Asia Protein Degradation Therapy Market Size by Type
9.2.1 Asia Protein Degradation Therapy Market Size by Type (2019-2024)
9.2.2 Asia Protein Degradation Therapy Market Size by Type (2025-2030)
9.2.3 Asia Protein Degradation Therapy Market Share by Type (2019-2030)
9.3 Asia Protein Degradation Therapy Market Size by Application
9.3.1 Asia Protein Degradation Therapy Market Size by Application (2019-2024)
9.3.2 Asia Protein Degradation Therapy Market Size by Application (2025-2030)
9.3.3 Asia Protein Degradation Therapy Market Share by Application (2019-2030)
9.4 Asia Protein Degradation Therapy Market Size by Region
9.4.1 Asia Protein Degradation Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Protein Degradation Therapy Market Size by Region (2019-2024)
9.4.3 Asia Protein Degradation Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Protein Degradation Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Protein Degradation Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Details
11.1.2 Arvinas Business Overview
11.1.3 Arvinas Protein Degradation Therapy Introduction
11.1.4 Arvinas Revenue in Protein Degradation Therapy Business (2019-2024)
11.1.5 Arvinas Recent Developments
11.2 Nurix Therapeutics
11.2.1 Nurix Therapeutics Company Details
11.2.2 Nurix Therapeutics Business Overview
11.2.3 Nurix Therapeutics Protein Degradation Therapy Introduction
11.2.4 Nurix Therapeutics Revenue in Protein Degradation Therapy Business (2019-2024)
11.2.5 Nurix Therapeutics Recent Developments
11.3 Kymera Therapeutics
11.3.1 Kymera Therapeutics Company Details
11.3.2 Kymera Therapeutics Business Overview
11.3.3 Kymera Therapeutics Protein Degradation Therapy Introduction
11.3.4 Kymera Therapeutics Revenue in Protein Degradation Therapy Business (2019-2024)
11.3.5 Kymera Therapeutics Recent Developments
11.4 C4 Therapeutics
11.4.1 C4 Therapeutics Company Details
11.4.2 C4 Therapeutics Business Overview
11.4.3 C4 Therapeutics Protein Degradation Therapy Introduction
11.4.4 C4 Therapeutics Revenue in Protein Degradation Therapy Business (2019-2024)
11.4.5 C4 Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Protein Degradation Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of ARV-110
Table 3. Key Players of ARV-471
Table 4. Key Players of Other
Table 5. Global Protein Degradation Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Protein Degradation Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Protein Degradation Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Protein Degradation Therapy Market Share by Region (2019-2024)
Table 9. Global Protein Degradation Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Protein Degradation Therapy Market Share by Region (2025-2030)
Table 11. Protein Degradation Therapy Market Trends
Table 12. Protein Degradation Therapy Market Drivers
Table 13. Protein Degradation Therapy Market Challenges
Table 14. Protein Degradation Therapy Market Restraints
Table 15. Global Protein Degradation Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Protein Degradation Therapy Revenue Share by Players (2019-2024)
Table 17. Global Top Protein Degradation Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Degradation Therapy as of 2023)
Table 18. Global Protein Degradation Therapy Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Protein Degradation Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Protein Degradation Therapy, Headquarters and Area Served
Table 21. Global Key Players of Protein Degradation Therapy, Product and Application
Table 22. Global Key Players of Protein Degradation Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Protein Degradation Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Protein Degradation Therapy Revenue Market Share by Type (2019-2024)
Table 26. Global Protein Degradation Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Protein Degradation Therapy Revenue Market Share by Type (2025-2030)
Table 28. Global Protein Degradation Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Protein Degradation Therapy Revenue Share by Application (2019-2024)
Table 30. Global Protein Degradation Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Protein Degradation Therapy Revenue Share by Application (2025-2030)
Table 32. North America Protein Degradation Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Protein Degradation Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Protein Degradation Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Protein Degradation Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Protein Degradation Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Protein Degradation Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Protein Degradation Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Protein Degradation Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Protein Degradation Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Protein Degradation Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Protein Degradation Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Protein Degradation Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Protein Degradation Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Protein Degradation Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Protein Degradation Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Protein Degradation Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Protein Degradation Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Protein Degradation Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Protein Degradation Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Protein Degradation Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Protein Degradation Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Protein Degradation Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Protein Degradation Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Protein Degradation Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Protein Degradation Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Protein Degradation Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Protein Degradation Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 64. Arvinas Company Details
Table 65. Arvinas Business Overview
Table 66. Arvinas Protein Degradation Therapy Product
Table 67. Arvinas Revenue in Protein Degradation Therapy Business (2019-2024) & (US$ Million)
Table 68. Arvinas Recent Developments
Table 69. Nurix Therapeutics Company Details
Table 70. Nurix Therapeutics Business Overview
Table 71. Nurix Therapeutics Protein Degradation Therapy Product
Table 72. Nurix Therapeutics Revenue in Protein Degradation Therapy Business (2019-2024) & (US$ Million)
Table 73. Nurix Therapeutics Recent Developments
Table 74. Kymera Therapeutics Company Details
Table 75. Kymera Therapeutics Business Overview
Table 76. Kymera Therapeutics Protein Degradation Therapy Product
Table 77. Kymera Therapeutics Revenue in Protein Degradation Therapy Business (2019-2024) & (US$ Million)
Table 78. Kymera Therapeutics Recent Developments
Table 79. C4 Therapeutics Company Details
Table 80. C4 Therapeutics Business Overview
Table 81. C4 Therapeutics Protein Degradation Therapy Product
Table 82. C4 Therapeutics Revenue in Protein Degradation Therapy Business (2019-2024) & (US$ Million)
Table 83. C4 Therapeutics Recent Developments
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Protein Degradation Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Protein Degradation Therapy Market Share by Type: 2023 VS 2030
Figure 3. ARV-110 Features
Figure 4. ARV-471 Features
Figure 5. Other Features
Figure 6. Global Protein Degradation Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Protein Degradation Therapy Market Share by Application: 2023 VS 2030
Figure 8. Cancer Case Studies
Figure 9. Neuroscience Case Studies
Figure 10. Other Case Studies
Figure 11. Protein Degradation Therapy Report Years Considered
Figure 12. Global Protein Degradation Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Protein Degradation Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Protein Degradation Therapy Market Share by Region: 2023 VS 2030
Figure 15. Global Protein Degradation Therapy Market Share by Players in 2023
Figure 16. Global Top Protein Degradation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Degradation Therapy as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Protein Degradation Therapy Revenue in 2023
Figure 18. North America Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Protein Degradation Therapy Market Share by Type (2019-2030)
Figure 20. North America Protein Degradation Therapy Market Share by Application (2019-2030)
Figure 21. North America Protein Degradation Therapy Market Share by Country (2019-2030)
Figure 22. United States Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Protein Degradation Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Protein Degradation Therapy Market Share by Type (2019-2030)
Figure 26. Europe Protein Degradation Therapy Market Share by Application (2019-2030)
Figure 27. Europe Protein Degradation Therapy Market Share by Country (2019-2030)
Figure 28. Germany Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Protein Degradation Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Protein Degradation Therapy Market Share by Type (2019-2030)
Figure 36. China Protein Degradation Therapy Market Share by Application (2019-2030)
Figure 37. Asia Protein Degradation Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Protein Degradation Therapy Market Share by Type (2019-2030)
Figure 39. Asia Protein Degradation Therapy Market Share by Application (2019-2030)
Figure 40. Asia Protein Degradation Therapy Market Share by Region (2019-2030)
Figure 41. Japan Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Protein Degradation Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Protein Degradation Therapy Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Protein Degradation Therapy Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Protein Degradation Therapy Market Share by Country (2019-2030)
Figure 51. Brazil Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Protein Degradation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Arvinas Revenue Growth Rate in Protein Degradation Therapy Business (2019-2024)
Figure 58. Nurix Therapeutics Revenue Growth Rate in Protein Degradation Therapy Business (2019-2024)
Figure 59. Kymera Therapeutics Revenue Growth Rate in Protein Degradation Therapy Business (2019-2024)
Figure 60. C4 Therapeutics Revenue Growth Rate in Protein Degradation Therapy Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies